Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Beverly HillsThis study is completed in the United States. It is testing pharmacokinetics of Aripiprazole for schizophrenia.
Multiple locations, including Garden Grove
This study is ongoing in Germany. It focuses on depression.
In Germany
This study is completed in China. It focuses on Anxiety.
In Hong KongThis study is completed in the United States. It focuses on ADHD.
In New YorkThis study is completed in the United States. It focuses on ADHD.
Multiple locations, including Beverly HillsThis study has public registry information in the United States. It is testing AXS-05 for Depression.
Multiple locations, including Little RockThis study has public registry information in the United States. It is testing latuda for Bipolarity.
In BostonThis study is completed in the United States. It is testing N-Acetylcysteine for Bipolarity.
In BostonThis study is completed in the United States. It is testing SPN-812 Administered With Psychostimulants for ADHD.
Multiple locations, including Little RockThis study is completed in the United States. It is testing long Term Tolerability and Safety of Atomoxetine for ADHD.
In Oklahoma CityThis study is active but not recruiting in the United States. It focuses on ADHD.
Multiple locations, including Little Rock